ASX
Botanix Pharmaceuticals Ltd
BOT:ASX•Healthcare
Sensitive ASX Announcement
FDA Mid-Cycle Review Meeting Successfully Completed
Published: 03/04/23, 08:40am (AEST)•2 pages